Biopharma R&D Pipeline Shrinks for First Time in 30 Years: Report
The biopharma research and development pipeline has contracted for the first time in three decades, as reported by Citeline. This decline marks a significant shift in the pharmaceutical landscape, where the number of drugs in development has seen a notable decrease. Factors contributing to this trend may include methodological changes in data collection and analysis,…








